JOURNAL ARTICLE

Baidu-Backed BioMap Is Said to Confidentially File for HK IPO.

  • Published In: Bloomberg.com, 2026. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Fioretti, Julia 3 of 3

Abstract

The article focuses on BioMap Beijing Intelligent Technology Co., a Baidu Inc.-backed artificial intelligence and life sciences startup, which has filed confidentially for a Hong Kong initial public offering (IPO) that could raise several hundred million dollars. Founded in 2020 by Baidu co-founder Robin Li and former Baidu Ventures CEO Liu Wei, BioMap develops AI systems to model biological mechanisms and enhance drug development efficiency. The company is working with China International Capital Corp., Morgan Stanley, and UBS Group AG on the IPO, amid growing investor interest in AI-driven drug discovery firms in Hong Kong. This trend coincides with a resurgence in the region’s biotech sector, marked by significant health-care IPO activity and a notable rise in the Hang Seng Biotech Index. [Extracted from the article]

Additional Information

  • Source:Bloomberg.com. 2026/03, pN.PAG
  • Document Type:Article
  • Subject Area:Biography
  • Publication Date:2026
  • Accession Number:192317637
  • Copyright Statement:Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.